|
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® TAQSCREEN MPX TEST, VERSION 2.0 FOR USE ON THE COBAS S 201 SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV
|
Back to Search Results |
|
| Catalog Number |
05969484190 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
03/09/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The serial number of the analyzer was (b)(6).The investigation did not determine a product issue.The primary root cause is the low viral concentration of the eqa sample, leading to stochastic detection as governed by the poisson distribution.
|
| |
|
Event or Problem Description
|
|
There was an allegation of a questionable hcv result with eqa proficiency samples tested with the cobas® taqscreen mpx test, version 2.0 for use on the cobas s 201 system.On (b)(6) 2026, the initial primary pool of 6 (pp6) and primary pool of 1 (pp1) results were non-reactive.On (b)(6) 2026, the retest of pp6 was non-reactive and the retest of pp1 was reactive for hcv.Repeat on a competitor platform, kehua, with a pp8 and pp1 was reactive for hcv.The sample was also repeated at another customer site and the pp6 was non-reactive and pp1 was reactive for hcv.
|
| |
|
Search Alerts/Recalls
|
|
|